| Literature DB >> 30907099 |
Krisztina Bottyán1, Lajos Kemény1,2, Zsanett Renáta Csoma1.
Abstract
Facial angiofibroma is the characteristic symptom and also a major diagnostic criterion for Bourneville-Pringle disease. The centrofacially localized hamartomatous tumours start to appear in early childhood, and progress over time. Facial angiofibromas represent a significant cosmetological problem for the patients and a therapeutic challenge for the physician. Beside the traditional invasive treating methods, topical sirolimus is a new, promising and well-tolerated treatment modality. Several studies and case reports have been published on this new therapeutic approach, but recommendation for the optimal sirolimus concentration still does not exist. We report here two cases when children were successfully treated with topical sirolimus. Orv Hetil. 2019; 160(13): 516-520.Entities:
Keywords: Bourneville–Pringle disease; Bourneville–Pringle-kór; adenoma sebaceum; angiofibroma; mTOR; sirolimus; szirolimusz
Mesh:
Substances:
Year: 2019 PMID: 30907099 DOI: 10.1556/650.2019.31244
Source DB: PubMed Journal: Orv Hetil ISSN: 0030-6002 Impact factor: 0.540